TKPHF - Takeda Pharmaceutical Company Limited (TAK) Q1 FY2025 Earnings Call Transcript

2025-07-30 11:50:53 ET

Takeda Pharmaceutical Company Limited (TAK)

Q1 FY2025 Earnings Call

July 30, 2025 6:00 A.M. ET

Company Participants

Furuta - Corporate Participant

O’Reilly - Corporate Participant

Plump - Corporate Participant

Weber - Corporate Participant

Conference Call Participants

Barker - Unidentified Company

Kim - Unidentified Company

Matsubara - Unidentified Company

Muraoka - Unidentified Company

Nedelcoyvch - Unidentified Company

Ueda - Unidentified Company

Wakao - Unidentified Company

Yamaguchi - Unidentified Company

Presentation

O’Reilly

[inaudible] joining us for FY2025 Q1 earnings announcement by Takeda despite your very busy schedule today. [inaudible] Head of IR. My name is O’Reilly. Thank you for this opportunity. I would like to explain about the language setting to begin with. Please find the language selection button at the bottom of your screen window. If you wish to listen in Japanese, please select the Japanese channel. If you wish, please choose the English channel. If you want to listen to the [inaudible] pleas sign it off. For those of you who wish to listen to this call in English, please select English in the Zoom language select button.

Before we begin, I would like to remind everyone that we'll be discussing forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those discussed today. The factors that could cause our actual results to differ materially are discussed in our most recent Form 20-F and in our other SEC filings. Please also refer to the important notice on page two of the presentation regarding forward-looking statements, non-IFRS financial measures, which will also be discussed during this call. Definitions of our non-IFRS measures and reconciliations with the comparable IFRS financial results are included in the appendix to the presentation....

For further details see: